BioNote, Inc. (KRX: 377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,770.00
-5.00 (-0.10%)
Dec 20, 2024, 9:00 AM KST

BioNote Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
266,544147,395681,067418,612123,0806,576
Short-Term Investments
134,560252,773672.4470,00040,000145.95
Trading Asset Securities
--39,722-40,5311,001
Cash & Short-Term Investments
401,103400,168721,461488,612203,6107,724
Cash Growth
-4.70%-44.53%47.66%139.97%2536.24%-
Accounts Receivable
22,84318,17416,37483,961310,5778,825
Other Receivables
1,3946,6901,930117.8186.83-
Receivables
24,23824,86418,30484,079310,6648,825
Inventory
24,87130,68379,03864,85953,0537,757
Prepaid Expenses
412.92500.11,76351.8620.1126.83
Other Current Assets
335261.774,2693,1076,080306.5
Total Current Assets
450,961456,478824,836640,709573,42824,638
Property, Plant & Equipment
89,72589,59497,15998,00749,65923,577
Long-Term Investments
1,078,9371,035,075827,748743,863229,70182,269
Goodwill
5,5125,5125,5125,512--
Other Intangible Assets
3,9144,7501,589354.16250.09304.89
Other Long-Term Assets
884.86491.43157.1422.15401.4942.45
Total Assets
1,631,2601,592,8421,757,0021,488,867853,440130,831
Accounts Payable
3,2733,5203,3025,41229,6702,316
Accrued Expenses
1,1191,5914,6899,5472,841360.26
Short-Term Debt
-----12,000
Current Portion of Leases
1,2951,334468.57295.95137.8241.68
Current Income Taxes Payable
4,445467.5635,15795,913139,103964.96
Other Current Liabilities
3,3003,8885,8897,10512,1601,200
Total Current Liabilities
13,43110,80149,505118,273183,91216,883
Long-Term Leases
2,5553,594893.3473.7206.6149.58
Long-Term Deferred Tax Liabilities
25,59121,652106,30097,51730,5933,291
Other Long-Term Liabilities
212.13219.19151.1199.2931.7530.3
Total Liabilities
41,78936,266156,850216,363214,74420,255
Common Stock
51,02851,02850,93846,7782,9242,924
Additional Paid-In Capital
82,74482,74480,99711,87755,73255,732
Retained Earnings
1,416,5341,392,8281,466,0341,207,900580,21751,991
Comprehensive Income & Other
40,67229,9762,1835,948-176.05-69.47
Shareholders' Equity
1,589,4711,556,5761,600,1521,272,504638,696110,577
Total Liabilities & Equity
1,631,2601,592,8421,757,0021,488,867853,440130,831
Total Debt
3,8504,9281,362769.65344.4412,091
Net Cash (Debt)
397,253395,240720,100487,842203,266-4,368
Net Cash Growth
-4.69%-45.11%47.61%140.00%--
Net Cash Per Share
3889.523871.057637.275206.962172.67-51.86
Filing Date Shares Outstanding
102.06102.06101.8893.5693.5684.22
Total Common Shares Outstanding
102.06102.06101.8893.5693.5684.22
Working Capital
437,530445,677775,331522,435389,5167,755
Book Value Per Share
15574.4915252.1715706.8513601.526826.881312.90
Tangible Book Value
1,580,0451,546,3131,593,0511,266,638638,446110,272
Tangible Book Value Per Share
15482.1315151.6115637.1513538.816824.211309.28
Land
38,35938,35914,54114,54114,54110,243
Buildings
23,98128,00225,23325,90519,47510,054
Machinery
13,83631,12238,87330,86517,4418,006
Construction In Progress
5,6272,00227,82135,3034,219346.55
Source: S&P Capital IQ. Standard template. Financial Sources.